The Vanguard Group's Position in Life Science REIT plc

The Vanguard Group, Inc. has issued a Form 8.3, disclosing its positions in Life Science REIT plc. As per the disclosure under Rule 8.3 of the Takeover Code, The Vanguard Group holds interests in Life Science REIT, representing 1% or more of the relevant securities.

The disclosure specifies that as of June 30, 2025, The Vanguard Group owns 3,326,566 ordinary shares, accounting for 0.95% of the company's securities. In the same period, they conducted a sale of 157,895 ordinary shares at 0.46 GBP per unit.

There are no cash-settled or stock-settled derivatives positions reported and no other dealings like new securities subscriptions. Additionally, there are no agreements, arrangements, or understandings regarding options or derivatives.